Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.
about
Transgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene.Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.Distinct strategies are required to suppress antigen-specific responses to genetically modified keratinocytes and fibroblasts.The effects of adenoviral transfection of the keratinocyte growth factor gene on epidermal stem cells: an in vitro study.Removal of transgene-expressing cells by a specific immune response induced by sustained transgene expression.
P2860
Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@ast
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@en
type
label
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@ast
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@en
prefLabel
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@ast
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@en
P2860
P356
P1433
P1476
Loss of transgene following ex ...... ns for cutaneous gene therapy.
@en
P2093
Soosan Ghazizadeh
Zhenmei Lu
P2860
P304
P356
10.1038/MT.SJ.6300086
P577
2007-03-13T00:00:00Z